DC Field | Value | Language |
dc.contributor.author | Ursu, Diana | - |
dc.contributor.author | Țîstoi, Tatiana | - |
dc.date.accessioned | 2020-10-09T10:53:20Z | - |
dc.date.available | 2020-10-09T10:53:20Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | URSU, Diana, ȚÎSTOI, Tatiana. Aortic valvulopathy in ochronosis. In: MedEspera: the 8th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2020, p. 30. | en_US |
dc.identifier.uri | https://medespera.asr.md/wp-content/uploads/ABSTRACT-BOOK.pdf | - |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/12049 | - |
dc.description | Department of Human Physiology and Biophysics Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 8th International Medical Congress for Students and Young Doctors, September 24-26, 2020 | en_US |
dc.description.abstract | Background. Ochronosis (alkaptonuria) is a very rare metabolic disease. This pathology has
an autosomal recessive transmission and is manifested by the progressive and irreversible
impairment of the connective tissue. Alkaptonuria occurs as a result of the innate defect of
tyrosine metabolism due to the homogentisic acid oxidase deficiency (enzymopathy), which
causes the accumulation of homogentisic acid in the collagen structures of the body. Clinical
manifestations of alkaptonuria are homogentisic aciduria, specific staining of conjunctival
structures (ochronosis) and arthropathy of large joints. Cardiovascular disorders involving the
aortic, mitral valve and coronary arteries in alkaptonuria are less common, and their incidence
remains unclear.
Case report. In this clinical report, we present the case of a 57-year-old female, with a history
of progressive blue pigmentation of the integuments, sclera and auricular cartilages, as well as
hyperchromic urine, which the patient reports having it since childhood. Four years ago, the
patient had total bilateral hip arthroplasty, and at the moment, presents with clinical signs of
severe aortic stenosis and ischemic cardiomyopathy.
Conclusions. We will refer to the etiology, pathogenesis, diagnosis and possibilities of
treatment during ochronosis discussion. In particular, we will describe the cardiac conditions
detected in this case, the intraoperative findings and the results of the surgical treatment
performed. | en_US |
dc.language.iso | en | en_US |
dc.publisher | MedEspera | en_US |
dc.subject | Alkaptonuria | en_US |
dc.subject | autosomal recessive disease | en_US |
dc.subject | blue pigmentation | en_US |
dc.subject | aortic valvulopathy | en_US |
dc.title | Aortic valvulopathy in ochronosis | en_US |
dc.type | Article | en_US |
Appears in Collections: | MedEspera 2020
|